National Institute of Mental Health (NIMH): Psychotic Disorders trials

The registry lists 13 Psychotic Disorders studies with National Institute of Mental Health (NIMH) as lead sponsor. 0 are open to participants now and 2 have results posted.

Phase 1 3Phase 2 3Phase 4 2No phase 6(a study in two phases counts in both)

Studies

Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Comparison of Antipsychotics for Metabolic Problems in Schizophrenia or Schizoaffective DisorderCompletedNCT00423878Phase 4Results posted
• Comparison of Clozapine vs Olanzapine in Childhood-Onset Psychotic DisordersCompletedNCT00001656Phase 4Results posted
• Daily Intranasal Oxytocin for Childhood-Onset SchizophreniaTerminatedNCT01712646Phase 1/2
• Functional Relevance of Dopamine Receptors in Healthy Controls and Patients With Schizophrenia: Characterization Through [11C]NNC-112 and [18F]Fallypride Positron Emission TomographyCompletedNCT00942981
• Transcranial Direct Current Brain Stimulation to Treat Patients With Childhood-Onset SchizophreniaTerminatedNCT00757497Phase 1
• Effects of Modafinil on Brain Function in Patients With SchizophreniaCompletedNCT00057707Phase 1
• Screening for Childhood-Onset Psychotic DisordersTerminatedNCT00049738
• Glycine to Treat Psychotic Disorders in ChildrenCompletedNCT00005658Phase 2
• Genetic Study of SchizophreniaCompletedNCT00001486
• New Drugs in the Treatment of Mood DisordersCompletedNCT00001482Phase 2
• Studies of Frontal Lobe Brain Functioning in SchizophreniaCompletedNCT00001258
• Inpatient Evaluation of Adults With SchizophreniaCompletedNCT00001247
• Evaluating Genetic Risk Factors for Childhood-Onset SchizophreniaTerminatedNCT00001198